Key facts
- This page summarizes Arpa Garay's Form 4 filing for Merck & Co., Inc. (MRK).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 May 2022, 17:24.
Arpa Garay - 03 May 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)
- Reporting relationship
- SVP Human Health Global Mktg.
- Issuer ticker
- MRK
- Reported as of
- 03 May 2022
- Net transaction value
- +$56,441
- SEC form
- 4
- Accepted by SEC
- 05 May 2022, 17:24:52 UTC
- Prior SEC filing
- 03 May 2022
- Next SEC filing
- 29 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly E. W. Grez, as attorney-in-fact for Arpa Garay
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Arpa Garay filed Form 4 for Merck & Co., Inc. (MRK) on 05 May 2022.
Change
- Previous filing in this sequence was filed on 03 May 2022.
- Current net transaction value: +$56,441.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRK
transaction
Common Stock
Options Exercise
- Transaction value
- $79,000
- Shares
- +907
- Change %
- +62%
- Price
- $87.10
- Shares after
- 2,368
- Date
- 04 May 2022
- Ownership
- Direct
MRK
transaction
Common Stock
Tax liability
- Transaction value
- $22,559
- Shares
- -259
- Change %
- -11%
- Price
- $87.10
- Shares after
- 2,109
- Date
- 04 May 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRK
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -907
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 1,819
- Date
- 04 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 907
- Exercise price
- Footnotes
- F2, F3
MRK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +21,359
- Change %
- Price
- $0.000000
- Shares after
- 21,359
- Date
- 03 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,359
- Exercise price
- $87.10
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Holdings include shares acquired in dividend reinvestment transactions.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
Footnote F3
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
Footnote F4
The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.